Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Scynexis Inc (SCYX)

Scynexis Inc (SCYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,140
  • Shares Outstanding, K 37,753
  • Annual Sales, $ 140,140 K
  • Annual Income, $ 67,040 K
  • 60-Month Beta 1.57
  • Price/Sales 0.40
  • Price/Cash Flow 0.77
  • Price/Book 0.75
Trade SCYX with:

Options Overview Details

View History
  • Implied Volatility 619.46% ( +266.20%)
  • Historical Volatility 95.37%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 619.46% on 04/29/24
  • IV Low 65.08% on 08/28/23
  • Put/Call Vol Ratio 0.07
  • Today's Volume 382
  • Volume Avg (30-Day) 64
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 1,857
  • Open Int (30-Day) 2,013

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.18
  • Number of Estimates 1
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +28.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3700 +32.85%
on 04/17/24
1.9500 -6.67%
on 04/29/24
+0.3500 (+23.81%)
since 03/28/24
3-Month
1.3500 +34.81%
on 03/19/24
2.1700 -16.13%
on 02/05/24
-0.1300 (-6.67%)
since 01/29/24
52-Week
1.3500 +34.81%
on 03/19/24
3.8700 -52.97%
on 09/05/23
-1.3300 (-42.22%)
since 04/28/23

Most Recent Stories

More News
Scynexis: Q3 Earnings Snapshot

Scynexis: Q3 Earnings Snapshot

SCYX : 1.8200 (+18.18%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. - SCYX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of SCYNEXIS, Inc. ("SCYNEXIS" or the "Company") (NASDAQ: SCYX). Such investors are...

SCYX : 1.8200 (+18.18%)
The Law Offices of Frank R. Cruz Announces Investigation of SCYNEXIS, Inc. (SCYX) on Behalf of Investors

/PRNewswire/ -- The Law Offices of Frank R. Cruz announces an investigation of SCYNEXIS, Inc. ("SCYNEXIS" or the "Company") (NASDAQ: SCYX) on behalf of...

SCYX : 1.8200 (+18.18%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. - SCYX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of SCYNEXIS, Inc. ("SCYNEXIS" or the "Company") (NASDAQ: SCYX). Such investors are...

SCYX : 1.8200 (+18.18%)
Scynexis: Q2 Earnings Snapshot

Scynexis: Q2 Earnings Snapshot

SCYX : 1.8200 (+18.18%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating SCYNEXIS, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

SCYX : 1.8200 (+18.18%)
Scynexis (SCYX) Reports Q1 Loss, Misses Revenue Estimates

Scynexis (SCYX) delivered earnings and revenue surprises of 10.71% and 24.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SCYX : 1.8200 (+18.18%)
GANX : 3.00 (-0.99%)
Scynexis: Q1 Earnings Snapshot

Scynexis: Q1 Earnings Snapshot

SCYX : 1.8200 (+18.18%)
Scynexis (SCYX) Inks Antifungal Drug Deal With GSK

Scynexis (SCYX) enters an exclusive license agreement with GSK to commercialize Brexafemme (ibrexafungerp), an antifungal tablet. GSK will also continue to develop ibrexafungerp for treating invasive candidiasis....

GSK : 41.61 (+1.22%)
NVO : 126.88 (+0.02%)
SCYX : 1.8200 (+18.18%)
JSPR : 21.92 (+7.45%)
SCYNEXIS (NASDAQ: SCYX) Enters Into Exclusive Agreement with GSK (NYSE: GSK) to Continue Commercializing Brexafemme to Treat Fungal Infections

SCYNEXIS, Inc. (NASDAQ: SCYX) operates as a biotechnology company, which is focused on the research and development of novel solutions

SCYX : 1.8200 (+18.18%)
GSK : 41.61 (+1.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

SCYNEXIS, Inc. is a pharmaceutical company. It is engaged in the discovery, development, and commercialization of anti-infectives to address unmet therapeutic needs. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of serious and life-threatening...

See More

Key Turning Points

3rd Resistance Point 2.3925
2nd Resistance Point 2.1713
1st Resistance Point 1.9956
Last Price 1.8200
1st Support Level 1.5987
2nd Support Level 1.3775
3rd Support Level 1.2018

See More

52-Week High 3.8700
Fibonacci 61.8% 2.9074
Fibonacci 50% 2.6100
Fibonacci 38.2% 2.3126
Last Price 1.8200
52-Week Low 1.3500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar